Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Premature termination of early-phase cancer clinical trials: "It's the economy, stupid!"

Journal of the National Cancer Institute·2026

Same author

Human nerve growth factor delivery to the retina: Quantitative methodology and mathematical modeling in preclinical settings.

PNAS nexus·2025

Same author

Ceramide as an endothelial cell surface receptor and a lung-specific lipid vascular target for circulating ligands.

Proceedings of the National Academy of Sciences of the United States of America·2023

Same author

Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.

Proceedings of the National Academy of Sciences of the United States of America·2021

Same author

Targeted AAVP-based therapy in a mouse model of human glioblastoma: a comparison of cytotoxic versus suicide gene delivery strategies.

Cancer gene therapy·2019

Same author

Fractions of Selaginella convoluta (Arn.) Spring (Selaginellaceae) attenuate the nociceptive behavior events in mice.

Brazilian journal of biology = Revista brasleira de biologia·2019

Search research articles

Related Experiment Video

Updated: Mar 1, 2026

Author Spotlight: Unveiling the Potential of Unpurified Recombinant AAVs in Cell Culture Research

Author Spotlight: Unveiling the Potential of Unpurified Recombinant AAVs in Cell Culture Research

Published on: October 20, 2023

An AAVP-based solid-phase transducing matrix for transgene delivery: potential for translational applications.

T L Smith^1,2, G R Souza^3,4, R L Sidman⁵

¹University of New Mexico Comprehensive Cancer Center, Albuquerque, NM, USA.

Cancer Gene Therapy

|May 27, 2017

Summary

Researchers developed a novel gold nanoparticle-AAVP hybrid vector, creating a "transducing matrix" for enhanced gene delivery. This nanoplatform significantly improves targeted gene delivery efficiency in solid phases, offering new therapeutic possibilities.

More Related Videos

Production, Purification, and Quality Control for Adeno-associated Virus-based Vectors

Production, Purification, and Quality Control for Adeno-associated Virus-based Vectors

Published on: January 29, 2019

AAV Deployment of Enhancer-Based Expression Constructs In Vivo in Mouse Brain

AAV Deployment of Enhancer-Based Expression Constructs In Vivo in Mouse Brain

Published on: March 31, 2022

Related Experiment Videos

Last Updated: Mar 1, 2026

Author Spotlight: Unveiling the Potential of Unpurified Recombinant AAVs in Cell Culture Research

Author Spotlight: Unveiling the Potential of Unpurified Recombinant AAVs in Cell Culture Research

Published on: October 20, 2023

Production, Purification, and Quality Control for Adeno-associated Virus-based Vectors

Production, Purification, and Quality Control for Adeno-associated Virus-based Vectors

Published on: January 29, 2019

AAV Deployment of Enhancer-Based Expression Constructs In Vivo in Mouse Brain

AAV Deployment of Enhancer-Based Expression Constructs In Vivo in Mouse Brain

Published on: March 31, 2022

Area of Science:

Biotechnology
Nanotechnology
Molecular Biology

Background:

Adeno-associated virus-phage (AAVP) hybrid vectors enable ligand-directed transgene delivery to tumors.
Previous studies show AAVP's potential in theranostic and therapeutic tumor applications.
Optimizing AAVP transduction efficiency remains an ongoing research area.

Purpose of the Study:

To enhance the translational utility of AAVP for targeted gene delivery.
To develop a novel nanoplatform by combining AAVP with gold nanoparticles.
To investigate the efficacy of this new platform in solid-phase gene delivery.

Main Methods:

Generation of a hybrid AAVP-gold nanoparticle 'transducing matrix'.
Evaluation of solid-phase transduction capabilities compared to conventional aqueous methods.
Assessment of in vitro cell assembly and transduction enhancement.
Exploration of potential modifications for imaging and therapeutic applications.

Main Results:

The AAVP-gold nanoparticle matrix demonstrates superior targeted gene delivery in solid phases.
The matrix exhibits stability and can be functionalized for advanced applications.
In vitro studies show spontaneous assembly around cells, markedly enhancing transduction.
Significant improvement in transduction capabilities compared to AAVP alone was observed.

Conclusions:

The AAVP-gold nanoparticle transducing matrix represents a significant advancement in targeted gene delivery.
This versatile nanoplatform offers improved transduction efficiency for therapeutic and theranostic applications.
Potential applications include complex tissue patterning and enhanced cancer gene therapy.